Recently, cardiovascular morbidity and mortality have been linked to particulate matter (PM) air pollution ([@b37-ehp0115-001012]; [@b46-ehp0115-001012]; [@b47-ehp0115-001012]; [@b65-ehp0115-001012]) and ranked as one of the most costly types of PM-related death ([@b19-ehp0115-001012]). The PM-associated activation of the autonomic nervous system, usually expressed as changes in heart rate variability (HRV), has been postulated as one of the major mechanisms linking PM exposures and their cardiovascular effects in the most recent studies ([@b5-ehp0115-001012]).

Epidemiologic studies ([@b18-ehp0115-001012]; [@b47-ehp0115-001012]; [@b48-ehp0115-001012]; [@b50-ehp0115-001012]), especially those focusing on HRV indices ([@b9-ehp0115-001012], [@b10-ehp0115-001012]; [@b17-ehp0115-001012]; [@b25-ehp0115-001012]; [@b53-ehp0115-001012]; [@b54-ehp0115-001012]; [@b61-ehp0115-001012]), have demonstrated that PM-mediated cardiovascular effects are heterogeneous, depending on particle contents. Animal models have been used to investigate the effects of different particles ([@b8-ehp0115-001012], [@b7-ehp0115-001012]; [@b14-ehp0115-001012]; [@b27-ehp0115-001012]; [@b34-ehp0115-001012], [@b35-ehp0115-001012]; [@b56-ehp0115-001012]). The cardiovascular toxicities were also demonstrated to be heterogeneous in toxicologic settings focusing on cytokine release ([@b29-ehp0115-001012]; [@b42-ehp0115-001012]), heart rate changes ([@b27-ehp0115-001012]; [@b60-ehp0115-001012]), electrocardiographic (ECG) changes ([@b26-ehp0115-001012]; [@b31-ehp0115-001012]; [@b60-ehp0115-001012]), and HRV indices ([@b13-ehp0115-001012]; [@b24-ehp0115-001012]). All of these toxicologic studies support the heterogeneity of PM cardiovascular effects. However, the underlying mechanisms remain to be explored.

Several studies have been devoted to determining the explanation for these observed heterogenic PM effects, including the vulnerability and host effects ([@b4-ehp0115-001012]; [@b49-ehp0115-001012]). It has also been postulated that the compositional characteristics of particles may contribute to their different health impacts ([@b45-ehp0115-001012]). This hypothesis is supported both by epidemiologic observations, and animal toxicologic research. The most appealing observations include the association between HRV indices and trajectory ([@b24-ehp0115-001012]; [@b44-ehp0115-001012]), and componential groups by statistical modeling ([@b43-ehp0115-001012]). These observations suggested that the cardiovascular effects of PMs varied significantly with their compositional characteristics. Our objectives in this study are to verify that different PM components can cause different cardioregulatory effects; that a single PM component exposure can cause different effects at different phases; and that combined exposure to multiple PM components can produce interactions modulating the final outcomes.

Materials and Methods
=====================

Experimental design
-------------------

We obtained 60-day-old male spontaneously hypertensive (SH) rats from the National Laboratory Animal Breeding and Research Center (Taipei, Taiwan). They were housed individually on Aspen chip bedding and provided with Lab Diet 5001 (PMI Nutrition International, Richmond, IN, USA) and water *ad libitum*. A 12-hr light/dark cycle, a constant room temperature, and a constant relative humidity were maintained in the animal room during the study.

SH rats were implanted with radio-telemetry transmitters at 11 weeks of age. Experiments were performed over a 2-week period, beginning 10 days after implantation. Phosphate buffered saline (PBS) was given via intratracheal (IT) instillation (under Sevoflurane general anesthesia; Abbott Laboratories Ltd., Queenborough, Kent, UK) at a volume of 0.25 mL per animal in the first week. Radiotelemetric data were subsequently collected for 72 hr, and this served as a baseline template in the analysis process. Materials to be tested were suspended or dissolved in PBS, and were given to the same animals on the same day and time the following week. Data collected for the next 72 hr served as the response data.

As shown in [Figure 1](#f1-ehp0115-001012){ref-type="fig"}, eight groups of experiments were performed. Test materials were dispersed or dissolved in 0.25 mL PBS: 14 nm ultrafine carbon black (ufCB; low-dose: 415 μg/animal, *n* = 4; and high-dose: 830 μg/animal, *n* = 4); ferric sulfate \[Fe~2~(SO~4~)~3~; low-dose: 105 μg/animal, *n* = 5; high-dose: 210 μg/animal, *n* = 3\]; and nickel sulfate (NiSO~4~; low-dose: 263 μg/animal, *n* = 5; high-dose: 526 μg/animal, *n* = 3). Concomitant exposures of 830 μg ufCB with 105 μg Fe~2~(SO~4~)~3~ (*n* = 4) or 263 μg NiSO~4~ (*n* = 4) in 0.25 mL PBS were also performed. All materials to be tested underwent ultrasonication for 30 min before IT instillation. The exposure dosages of ufCB were previously determined in our laboratory. The low exposure dosages of Fe~2~(SO~4~)~3~ and NiSO~4~ were comparable with those used in previous works ([@b7-ehp0115-001012]); we then doubled those doses to investigate more significant HRV changes. All protocols used in this study were approved by the Committees on Use and Care of Animals of the National Taiwan University. All SH rats used in this study were treated humanely according to institutional guidelines, with appropriate consideration for the alleviation of suffering and distress.

Heart rate variability measurements
-----------------------------------

The methodology of HRV measurements with the radiotelemetry system has been described previously ([@b11-ehp0115-001012], [@b12-ehp0115-001012]; [@b15-ehp0115-001012]). Briefly, we collected all ECG signals throughout the study on a continuous basis. The sampling rates for the ECG signals were set at 1,000 points per second (1,000 Hz) for better temporal discrimination.

Time intervals between adjacent R waves in the ECG recording (RR) were calculated on a beat-to-beat basis using Dataquest A.R.T. Analysis software, version 2.20 (Data Sciences International, St. Paul, MN, USA). To obtain normal-to-normal (NN) intervals, we used a computer algorithm based on the recommendation by [@b16-ehp0115-001012] to eliminate type A and type B errors in NN calculation. Basically, the NN calculation followed a two-step procedure: the increase or decrease of any RR compared with the previous RR was limited to 33% in a step-1 correction, and data points with distances to the median \> 1.5 SDs on Lorenz plots were eliminated in step 2 for every 30 min. The 5-min SD of the normal-to-normal intervals (SDNN) and the root mean square of successive differences of adjacent normal-to-normal intervals (RMSSD) were then calculated from these NN data sets.

Statistical analysis
--------------------

Owing to individual variation among diseased animals, conventional exposure--control experimental designs would necessitate a large sample size to demonstrate minute effects under strong confounding conditions, a scenario commonly seen in the study of PM toxicology. Furthermore, the circadian nature of cardiovascular parameters often complicates the analysis. Thus, we used a self-control experimental designs in this research. Exposures were carried out at the same time (starting from 1200 hours) on Tuesday of two consecutive weeks. Data collected in the first week (animals exposed to PBS alone) served as the control group for those collected in the following week (animals exposed to test materials).

We calculated the SDNN and RMSSD as described previously ([@b12-ehp0115-001012]). Average NN intervals (ANN) and natural logarithm transformation of SDNN (LnSDNN) and RMSSD (LnRMSSD) were used as outcome measurements to produce approximately symmetrical distributions of response variables for statistical analysis. Time plots of the original data are shown in [Figure 2](#f2-ehp0115-001012){ref-type="fig"}.

We calculated hourly means of the control group data of all three HRV parameters (ANN, LnSDNN, and LnRMSSD); these hourly means served as circadian templates in the analytic procedures. To better illustrate particle effects, we subtracted the hourly means from all 5-min data from each HRV parameter to obtain crude effects, which were then used for the computation of 6-hr average crude effects.

We used the generalized estimation equation (GEE) model to further examine the exposure effect during the 72-hr observation period. We modeled the exposure effects with a set of 13 dummy variables, each standing for average crude effects of the 1-hr preparation and 6-hr succeeding time segments. *Y~it~* is the average crude effect for the *i*th SH rat at time *t* = 0, 1, 2, ... 12, in which *t* = 0 corresponds to the 1-hr preparation, and the following time points correspond to the 12 6-hr sections during the 72-hr observation period. For adjusting rat-to-rat variation and control group effects, dummy variables for the number (*n*) of animals and the 13 HRV parameter values *B~t~* obtained in the first week are included in the model. Specifically, the GEE model is given by
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where *i* = 1, ..., *n*, *t* = 0, 1, 2, ... 12, and *I* (·) is an indicator function. We chose the error term ɛ*~it~* to be an autoregressive process with order 1 to model time dependence. The coefficients α*~m~* , for *m* = 0, 1, 2, ... 12, were used to describe the 6-hr mean exposure effects during the 72-hr observation period. Because the SH rats were randomly selected from a population, in addition to the overall difference parameter β~1~*~i~* , we added random components *a~mi~* to model the rat-to-rat variation of these effects. All of these random coefficients were assumed to be normally distributed with the mean of 0 and some constant variances. The time plots of the estimation of 6-hr means and 95% confidence intervals (CIs) were generated to provide an overall impression of the data.

The exposure effects of high-dose ufCB and low-dose Fe~2~(SO~4~)~3~ or NiSO~4~ were used to generate two virtual series by temporal summation of means and variances of the data from every 6 hr. These two virtual series were defined as the expected combined effects. Time plots of real combined effects of high dose ufCB and low dose Fe~2~(SO~4~)~3~ or NiSO~4~ were used to analyze the interactions between ufCB and Fe~2~(SO~4~)~3~ or NiSO~4~.

We used SAS 8.2 statistical software package (SAS Institute, Cary, NC, USA) to manage data and estimate the parameters and standard errors in the models.

Results
=======

Exposure effects
----------------

The GEE model--estimated exposure effects of ufCB, Fe~2~(SO~4~)~3~, and NiSO~4~ are shown in [Figure 3](#f3-ehp0115-001012){ref-type="fig"}. As shown in [Figure 3](#f3-ehp0115-001012){ref-type="fig"}, for both low-dose (415 μg) and high-dose (830 μg) ufCB exposures, the ANN basically exhibited a borderline depressed level centering around 30 hr after exposure ([Figure 3A](#f3-ehp0115-001012){ref-type="fig"}). Increased LnSDNN was followed by nonsignificant changes ([Figure 3D](#f3-ehp0115-001012){ref-type="fig"}). Initially elevated LnRMSSD followed a back-to-baseline trend 6 hr after exposure ([Figure 3G](#f3-ehp0115-001012){ref-type="fig"}).

Exposure to low-dose (105 μg) Fe~2~(SO~4~)~3~ resulted in increased LnSDNN at the end of the 72-hr observation ([Figure 3E](#f3-ehp0115-001012){ref-type="fig"}). The increase in LnRMSSD was small and persistent, and reached significance in the latter half of the observation period ([Figure 3H](#f3-ehp0115-001012){ref-type="fig"}). Exposure to high-dose (210 μg) Fe~2~(SO~4~)~3~ resulted in significantly biphasic responses in ANN ([Figure 3B](#f3-ehp0115-001012){ref-type="fig"}) and LnRMSSD ([Figure 3H](#f3-ehp0115-001012){ref-type="fig"}), which increased in the first 24 hr and decreased in the last 24 hr. Increased LnSDNN in the first and last 24 hr, however, rendered the responses multimodal ([Figure 3E](#f3-ehp0115-001012){ref-type="fig"}).

The exposure effects of NiSO~4~ are shown in [Figure 3C, 3F, and 3I](#f3-ehp0115-001012){ref-type="fig"}. Exposure to low-dose (263 μg) NiSO~4~ did not generate prominent responses in HRV measurements. In contrast, exposure to high-dose (516 μg) NiSO~4~ resulted in biphasic responses in all three measurements, which increased in the first 24 hr and decreased in the last 24 hr.

Expected and real combined effects
----------------------------------

The expected and real combined effects are illustrated in [Figure 4](#f4-ehp0115-001012){ref-type="fig"}. The expected combined effects in both Fe~2~(SO~4~)~3~ and NiSO~4~ basically followed similar trends. Compared with the expected combined effects, the real combined effects of ufCB and Fe ~2~ (SO ~4~ ) ~3~ tend to demonstrate milder changes in all three parameters during the 36 hr after exposure. In the combined exposure of ufCB and NiSO~4~, the real combined effects had a tendency to show more prominent changes in all three parameters during the same period. For the last 24 hr, the real combined effects for both groups tracked comparable trends, and were frequently separated from the expected combined effects.

Discussion
==========

Dose responses to ufCB
----------------------

Effects of high-dose ufCB were not obviously different from those of low-dose ufCB. According to [@b28-ehp0115-001012], the decrease in ANN around 30 hr after ufCB instillation might reflect low-grade but significant pulmonary inflammation. Failure of high-dose ufCB to induce more prominent responses might be due to aggregation effects. Although ultrasonication was applied to all materials before instillation, the aggregation of ufCB still should be considered, particularly when the concentrations are high ([@b22-ehp0115-001012]).

Dose and phased responses to Fe~2~(SO~4~)~3~ or NiSO~4~
-------------------------------------------------------

Whereas reactions to low-dose Fe~2~(SO~4~)~3~ and NiSO~4~ were modest, the responses to high doses were noticeably biphasic in the present study. [@b7-ehp0115-001012] found that low-dose Fe~2~(SO~4~)~3~ produced no obvious changes in heart rate and core body temperature on monocrotaline-induced pulmonary hypertensive Sprague-Dawley rats, whereas NiSO~4~ demonstrated acute bradycardia. In the present study, we found increased LnSDNN and LnRMSSD toward the end of the 72-hr observation period in response to the same level of Fe~2~(SO~4~)~3~. Exposure to low-dose NiSO~4~ did not result in significant HRV changes. We thus tested the HRV responses to "double-dosed" exposures, and demonstrated biphasic effects. The difference of the effects between these studies might have derived from model dissimilarity ([@b11-ehp0115-001012]; [@b15-ehp0115-001012]).

Decreased ANN and LnSDNN 48 hr after IT instillation of Ni are comparable with the most recent study found on ApoE^--/--^ (apolipoprotein deficient) mice by inhalation of Ni-rich concentrated ambient particles ([@b44-ehp0115-001012]). Biological plausibility of Ni-induced cardiovascular effects was well reviewed in their work and is applicable to our results. The discrepancy between response phases may be caused by differences in the model and the experimental design.

Significance and possible mechanisms of phased responses
--------------------------------------------------------

Single-phased and dose-dependent decreases in heart rate have been demonstrated in SH rats after IT instillation of an oil combustion--derived PM rich in transition metals ([@b62-ehp0115-001012]). Although biphasic heart rate and thermoregulatory effects have been demonstrated in cardiopulmonary-compromised rats exposed to residual oil fly ash ([@b6-ehp0115-001012]; [@b57-ehp0115-001012]), this is not the case in single component exposures. Conversely, exposure to high-dose Fe~2~(SO~4~)~3~ and NiSO~4~ generated biphasic changes in all three parameters in the present study. To the best of our knowledge, this is the first study to demonstrate biphasic HRV responses to single component exposures.

We have speculated that the time lag and complex interplay among incoming C-fiber stimulation, reactive oxygen species (ROS) production ([@b1-ehp0115-001012]; [@b3-ehp0115-001012]; [@b23-ehp0115-001012]; [@b66-ehp0115-001012]), and inflammation with proinflammatory cytokines release ([@b21-ehp0115-001012]; [@b30-ehp0115-001012]; [@b32-ehp0115-001012]; [@b38-ehp0115-001012], [@b39-ehp0115-001012], [@b40-ehp0115-001012]; [@b51-ehp0115-001012]; [@b55-ehp0115-001012]; [@b64-ehp0115-001012]) might all contribute to the synthesis of the observed biphasic responses. However, this speculation warrants further testing and verification.

Interactions between ufCB and/or Fe~2~(SO~4~)~3~ or NiSO~4~
-----------------------------------------------------------

The expected combined effects are the virtual series generated by temporal summation of means and variances of the real exposure effects of high-dose ufCB and low-dose Fe~2~(SO~4~)~3~ or NiSO~4~. Because the aim of the present study was to examine interactions between ufCB and transition metals, we selected transition metals at doses that produced minimal HRV effects: low-dose Fe~2~(SO~4~)~3~ and NiSO~4~. Because neither low nor high doses of ufCB generate significantly different HRV effects, we chose high-dose ufCB for more complete "absorption" of transition metals on the carbonaceous surfaces. In the present study, combined exposures of ufCB and Fe~2~(SO~4~)~3~ or NiSO~4~ demonstrated real combined effects that were significantly different from the expected combined effects. These trends verified significant interactions between the exposure components.

Transition metals have demonstrated interactions on cardioregulatory and thermo-regulatory effects ([@b7-ehp0115-001012]). Interactions between ufCB and Fe were also verified on pulmonary inflammation and ROS production ([@b63-ehp0115-001012]). We speculate that these interactions might involve a complex interplay among chelating/leaching kinetics, inflammatory processes, and ROS reactions ([@b2-ehp0115-001012]). Ambient ufCB and transition metals provoke different cardioregulatory effects when administered jointly, and these effects might be augmented in compromised vulnerable subjects. This speculation deserves further research and verification.

Experimental niches and limitations
-----------------------------------

### IT under general anesthesia

To precisely control the dosage, we used IT instillation as the exposure route. However, this procedure is considered invasive and less physiologic ([@b20-ehp0115-001012]) and requires general anesthesia. We chose the ultra-short inhalation anesthetic Sevoflurane to shorten the postanesthetic recovery to within 2 min, and we discarded data acquired within the first hour. This new and improved technology has minimized the anesthesia-associated variations to a negligible level. IT instillation disperses the particles evenly throughout most airways independent of particle size ([@b41-ehp0115-001012]). We believe that, within the lung, the pattern of distribution of instilled ufCB, Ni, and Fe compounds is similar, and that the response discrepancy might not have originated from distribution pattern differences.

### SH rats

[@b36-ehp0115-001012] and [@b58-ehp0115-001012] observed exacerbated cardiopulmonary injury and oxidative stress in SH rats exposed to PM and concluded that the SH rat is a potentially useful model to study the susceptibility to PM effects on the cardiovascular system. In the present study we used SH rats as an oxidation-deficient animal model, and we suggest that this model might be useful in assessing the potential biological plausibility linking PM exposures and the cardioregulatory effects in subpopulations with increased oxidative stress ([@b49-ehp0115-001012]). Although SH rats have been suggested to be suitable for mimicking human essential hypertensive subgroups ([@b52-ehp0115-001012]), their pathophysiology may not completely match that of humans ([@b59-ehp0115-001012]). Extrapolation of these PM-associated cardiovascular effects to human beings deserves further studies on healthy controls, including Wistar-Kyoto rats.

### Time domain HRV

In the present study, only time domain HRV parameters were used to measure the cardioregulatory effects, sparing the more sophisticated frequency domain parameters. However, we have previously demonstrated the applicability of these parameters ([@b12-ehp0115-001012]) and the correlation with other hemodynamic indices ([@b11-ehp0115-001012]). Owing to the close correlations among these parameters and those of frequency domain ([@b33-ehp0115-001012]), this limitation does not seriously restrict the interpretation of results. Besides, the index ANN is equivalent to the inverse of heart rate in beats per minute. The use of ANN may cause some inconvenience in biologic interpretation, but it complies with HRV analysis for better symmetry of data distribution.

### Statistical strategy and experimental design

Owing to technical demands, large-scaled experiments were impractical in our study. We used self-control experimental designs and GEE models to remedy the interference introduced by the relatively small sample size. In contrast, only three PM components were used in the present study, sparing many others. These factors have limited the scope of the study to some extent. However, to the best of our knowledge, this is the first study investigating the interactions between ufCB and transition metals on HRV and might indicate further investigations on many other major PM components for their dynamic effects and potential interactions.

### Concomitant exposure to ufCB and transition metals

In the present study, we presume that administering Ni or Fe individually is comparable to having these two substance leach from ufCB once instilled. A recent study investigating the interaction between 14 nm ufCB and transition metals on pulmonary inflammation and ROS formation also used a similar approach ([@b63-ehp0115-001012]). However, the kinetics of Ni or Fe leaching from ufCB has not been completely studied. We suggest that caution is required in interpretation before more detailed binding/leaching kinetics are available.

Conclusion
==========

In the present study, we demonstrated that ufCB has different cardioregulatory effects at different phases. The HRV responses to high-dose Fe~2~(SO~4~)~3~ and NiSO~4~ were noticeably biphasic, although the reactions to low-dose exposures were modest. Whereas the dose effects of Fe~2~(SO~4~)~3~ and NiSO~4~ were obvious, those for ufCB were obscure. Concurrent exposure to ufCB and Fe~2~(SO~4~)~3~ or NiSO~4~ introduced cardioregulatory responses that were more significant than those to single-component exposures.

We concluded that different components in PM might induce different cardioregulatory effects. A single-component exposure might also induce different effects at different phases, resulting in biphasic or even more complex cardioregulatory responses. Combined exposure to multiple components could introduce interactions among copollutants, and temporal summation of componential toxic responses might not be appropriate in the estimation of cardiovascular effects in real-life exposures.
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[^1]: The authors declare they have no competing financial interests.
